Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predementia phase, but validated diagnostic approaches are currently lacking. In this paper, we present the background, design and methods of a study, which aims to develop clinical criteria for predementia AD. We also present baseline characteristics of the subjects included. The study was part of the multicentre DESCRIPA project, which is being conducted within the network of the European Alzheimer's Disease Consortium. Methods: Clinical criteria will be based on a prospective cohort study of non-demented subjects older than 55 years and referred to a memory clinic. At baseline, a number of markers and risk factors for AD were collected, includin...
Abstract Background Deep phenotyping and longitudinal assessment of predementia at-risk states of Al...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
International audiencePreclinical Alzheimer's disease (AD) is a relatively recent concept describing...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...
Item does not contain fulltextBACKGROUND: There is an urgent need to identify subjects with Alzheime...
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the...
In view of the growing prevalence of Alzheimer's disease (AD) worldwide, there is an urgent need for...
There is growing recognition that the pathophysiological process of Alzheimer disease (AD) begins ma...
Increasing interest in clinical trials and clinical research settings to identify Alzheimer's diseas...
Background: The NIA-AA research framework proposes a purely biological definition of Alzheimer’s dis...
Background: To explore the utility of the International Working Group (IWG)-1 criteria in recruitmen...
Abstract Background Deep phenotyping and longitudinal assessment of predementia at-risk states of Al...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
International audiencePreclinical Alzheimer's disease (AD) is a relatively recent concept describing...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...
Item does not contain fulltextBACKGROUND: There is an urgent need to identify subjects with Alzheime...
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the...
In view of the growing prevalence of Alzheimer's disease (AD) worldwide, there is an urgent need for...
There is growing recognition that the pathophysiological process of Alzheimer disease (AD) begins ma...
Increasing interest in clinical trials and clinical research settings to identify Alzheimer's diseas...
Background: The NIA-AA research framework proposes a purely biological definition of Alzheimer’s dis...
Background: To explore the utility of the International Working Group (IWG)-1 criteria in recruitmen...
Abstract Background Deep phenotyping and longitudinal assessment of predementia at-risk states of Al...
Alzheimer disease (AD) represents the most common neurodegenerative disease worldwide, accounting fo...
International audiencePreclinical Alzheimer's disease (AD) is a relatively recent concept describing...